FutureBotanica, 1871 Cannabis Innovation Lab's Pitch, and Bloom Burton & Co. Healthcare Investor Conference

Announcing FutureBotanica 2024

Canurta Therapeutics is excited to unveil the premier event for botanical drug ideas of tomorrow, FutureBotanica 2024. Taking place on June 19, 2024, at the Ace Hotel in Toronto, this event brings together leading voices and trailblazers in biotechnology and life sciences.

Do not miss this opportunity to join industry leaders, innovators, and experts as we explore crucial themes in Botanical Drug Development, Technology Excellence, and Sustainability. Prepare for a day filled with insightful discussions and exclusive networking opportunities.

1871 Cannabis Innovation Lab's Pitch and Startup Alley Showcase

We are pleased to share our participation in the 1871 Cannabis Innovation Lab's Pitch and Startup Alley showcase in Chicago on April 16-17. This event provided us with a platform to present and network with cannatech industry leaders, innovators and investors.

Our presence at the showcase allowed us to highlight our achievements and the unique benefits and functionalities of our multi-target botanical drugs compared to traditional drug targets and development.

Bloom Burton & Co. Healthcare Investor Conference

In addition to our participation at the 1871 Cannabis Innovation Lab’s Pitch, our Head of Operations and People and Culture Lead attended the Bloom Burton & Co. Healthcare Investor Conference in Toronto. This event united leading Canadian healthcare companies and global investors, to discuss the latest developments and venture opportunities within the healthcare industry.

Providing insights into the activities, strategies, and current endeavours of advanced-stage companies within the healthcare sector, as well as the latest advancements and strategic directions of Canada's leading publicly traded and venture-backed private companies.

Click here to read more.

Bronze Sponsor at the ALS Society of Canada Research Forum 2024

We are proud to have sponsored the ALS Society of Canada Research Forum 2024, which took place on April 27-29. We value the opportunity to engage with the Canadian researchers committed to understanding ALS and assist in the development of effective treatments. We remain committed to pushing the boundaries of what we can achieve together in the realm of healthcare and biotechnology.

Become a Cannabis CEO Event

On April 30, Canurta Therapeutics' CEO Akeem Gardner will participate in the Become a Cannabis CEO event, which will commence at 6:00 p.m. in the G Commons on the Humber College Lakeshore campus. Akeem will share his journey of entrepreneurship, offering valuable business insights and practical advice to help others advance their careers in the industry.

Canurta's April Milestones

Research & Development

Solid Lipid Nanoparticle Formulation: Currently developing a solid lipid nanoparticle formulation to assist our molecules in crossing the blood-brain barrier.

Digital Transformation

New Extraction Technology: Our research manufacturing partner, Innofibre, continues its work optimizing our new extraction technology.

Bioinformatics

PCA Fingerprinting Pipeline: The bioinformatics team made significant progress in developing a PCA fingerprinting pipeline as part of Canurta’s standard operating procedure. This quality control technique is aimed at enhancing our capabilities to ensure batch consistency across our products. The new pipeline will allow for more precise and efficient identification of batch variations, thereby maintaining the high quality and reliability of our output.